Homepage About Andromeda Product Clinical Trials News Contact us
Product Description


Profile of DiaPep277®

DiaPep277® is a synthetic peptide of 24 amino acids derived from the sequence of the human heat shock protein 60 (Hsp60). The peptide modulates the immune response that leads to autoimmune diabetes by diminishing or blocking the immunological destruction of beta cells. Treatment of type 1 diabetes patients with DiaPep277® may have several medical benefits including prevention of disease deterioration, improved glycemic control, reduction of daily insulin dose requirements, and delay or reduction of diabetic complications.

Who may benefit from DiaPep277®
  • Newly diagnosed adult with type 1 diabetes
  • Newly diagnosed child or adolescent with type 1 diabetes
  • LADA patients
  • People with a high risk of developing type 1 diabetes 

Websites Design, Development ans SEO Loolweb marketing